Diabetes Care. 2007 Jan;30(1):162-72.

Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.

Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg R, Stitzel KF, Stone NJ; American Heart Association; American Diabetes Association.

Source

University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.

Abstract

The American Heart Association (AHA) and the American Diabetes Association (ADA) have each published guidelines for cardiovascular disease prevention: the ADA has issued separate recommendations for each of the cardiovascular risk factors in patients with diabetes, and the AHA has shaped primary and secondary guidelines that extend to patients with diabetes. This statement will attempt to harmonize the recommendations of both organizations where possible but will recognize areas in which AHA and ADA recommendations differ.

Comment in

Diabetes Care. 2007 Jun;30(6):e57; author reply e58.

PMID:: 17192355; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Supplemental Content

Save items

Related citations in PubMed

Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. [Circulation. 2007]
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.
Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, et al. Circulation. 2007 Jan 2; 115(1):114-26. Epub 2006 Dec 27.
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association: response to Buse et al. [Diabetes Care. 2007]
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association: response to Buse et al.
Nicolucci A, De Berardis G, Sacco M, Tognoni G. Diabetes Care. 2007 Jun; 30(6):e57; author reply e58.
Review of an article: aspirin for primary prevention of cardiovascular events in people with diabetes. A position statement of the American Diabetes Association (ADA), a scientific statement of the American Heart Association(AHA), and an expert consensus document of the American College of Cardiology Foundation (ACCF). Diabetes Care, 33:6; June 2010; 1395-1402. [J Vasc Nurs. 2010]
Review of an article: aspirin for primary prevention of cardiovascular events in people with diabetes. A position statement of the American Diabetes Association (ADA), a scientific statement of the American Heart Association(AHA), and an expert consensus document of the American College of Cardiology Foundation (ACCF). Diabetes Care, 33:6; June 2010; 1395-1402.
Gilpin VL, American Diabetes Association, American Heart Association, American College of Cardiology Foundation. J Vasc Nurs. 2010 Dec; 28(4):154-5.
Review [Critical analysis of the American Diabetes Association dietary recommendations for cardiovascular disease in diabetes mellitus]. [Arq Bras Endocrinol Metabol. 2...]
Review [Critical analysis of the American Diabetes Association dietary recommendations for cardiovascular disease in diabetes mellitus].
Santos AL, Weiss T, Duarte CK, Azevedo MJ, Zelmanovitz T. Arq Bras Endocrinol Metabol. 2009 Jul; 53(5):657-66.
Review Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. [Circulation. 2009]
Review Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.
Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, et al. Circulation. 2009 Jan 20; 119(2):351-7. Epub 2008 Dec 17.

See reviews... See all...

Cited by 39 PubMed Central articles

Effects of atorvastatin and rosuvastatin on high-sensitivity C-reactive protein and lipid profile in obese type 2 diabetes mellitus patients. [J Pharmacol Pharmacother. 2011]
Effects of atorvastatin and rosuvastatin on high-sensitivity C-reactive protein and lipid profile in obese type 2 diabetes mellitus patients.
Sindhu S, Singh HK, Salman MT, Fatima J, Verma VK. J Pharmacol Pharmacother. 2011 Oct; 2(4):261-5.
Study rationale and design of OPTIMISE, a randomised controlled trial on the effect of benchmarking on quality of care in type 2 diabetes mellitus. [Cardiovasc Diabetol. 2011]
Study rationale and design of OPTIMISE, a randomised controlled trial on the effect of benchmarking on quality of care in type 2 diabetes mellitus.
Nobels F, Debacker N, Brotons C, Elisaf M, Hermans MP, Michel G, Muls E, OPTIMISE (OPtimal Type 2 dIabetes Management Including benchmarking and Standard trEatment) International Steering Committee. Cardiovasc Diabetol. 2011 Sep 22; 10:82. Epub 2011 Sep 22.
Diabetes mellitus and cardiovascular prevention: the role and the limitations of currently available antiplatelet drugs. [Int J Vasc Med. 2011]
Diabetes mellitus and cardiovascular prevention: the role and the limitations of currently available antiplatelet drugs.
Tufano A, Cimino E, Di Minno MN, Ieranò P, Marrone E, Strazzullo A, Di Minno G, Cerbone AM. Int J Vasc Med. 2011; 2011:250518. Epub 2011 Jun 30.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Primary prevention of cardiovascular diseases in people with diabetes mellitus: ...
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.
Diabetes Care. 2007 Jan ;30(1):162-72.

PubMed
Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and ham...
Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV.
J Virol. 1991 Dec ;65(12):6881-91.

PubMed
Lifestyle interventions are cost-effective in people with different levels of di...
Lifestyle interventions are cost-effective in people with different levels of diabetes risk: results from a modeling study.
Diabetes Care. 2007 Jan ;30(1):128-34.

PubMed
Conserved determinants for membrane association of nonstructural protein 5A from...
Conserved determinants for membrane association of nonstructural protein 5A from hepatitis C virus and related viruses.
J Virol. 2007 Mar ;81(6):2745-57. Epub 2006 Dec 27 .

PubMed
Aurintricarboxylic acid inhibits the early stage of vaccinia virus replication b...
Aurintricarboxylic acid inhibits the early stage of vaccinia virus replication by targeting both cellular and viral factors.
J Virol. 2007 Mar ;81(6):3027-32. Epub 2006 Dec 27 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: